Lineage Cell Therapeutics, Inc. (LCTX)

NYSE American • Currently down 0.05 (-6.10%) in today's trading session

Track congressional stock trades in Lineage Cell Therapeutics, Inc. (LCTX). Analyse trading activity from Nancy Pelosi and other members of Congress using public financial disclosure data.

Lineage Cell Therapeutics, Inc. is currently trading at $0.77, positioned at 0% of its 52-week range ($0.77 – $1.99).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$0.77
24h Change
-0.05 (-6.10%)
52 Week Range
$0.77–$1.99
View on NASDAQ

Lineage Cell Therapeutics, Inc. Price History and Technical Analysis

Congressional Trading Activity for LCTX

Select to highlight on chart
0 transactions
Compliance: 100%
No data

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$195.26M

Volume

2.04M

Beta

1.69

P/E Ratio

-4.15

Fundamentals

EPS

$-0.19

Div. Yield

-

Open

$0.82

Day Range

$0.77 – $0.83

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
AMEX · USD
Country
US
CEO
Brian Culley
IPO Date
1992-03-05

Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, developing cell replacement therapies to treat serious medical conditions in the United States and internationally. The company develops OpRegen, an allogeneic retinal pigment e...

Earnings

Next Report

Q4 2026

4 Mar

EPS Est.

$-0.02

Rev. Est.

$4.5M

Days Until

102

Recent Quarters

Q3 202612 Nov
EPS$-0.03
Miss 5.0%
Q3 20265 Nov
EPS-
Q2 20266 Aug
EPS$-0.03
Miss 5.9%
Q1 202612 May
EPS$-0.03
Miss 50.0%
Q4 20255 Mar
EPS$0.00
Beat 109.2%
Q3 20256 Nov
EPS$-0.13
Miss 550.0%
Q2 202512 Aug
EPS$-0.01
Beat 50.0%
Q1 202513 May
EPS$-0.02
Beat 0.0%
Q4 202410 Mar
EPS$-0.01
Beat 75.0%
Q3 202414 Nov
EPS$-0.02
Miss 53.5%
Q2 20248 Aug
EPS$-0.03
Beat 40.0%
Q1 20249 May
EPS$-0.04
Miss 4.4%
Q4 20237 Mar
EPS$-0.03
Miss 30.0%
Q3 20239 Nov
EPS$-0.04
Miss 6.7%
Q2 202310 Aug
EPS$-0.03
Miss 32.3%
Q1 202311 May
EPS$-0.03
Miss 21.8%
Q4 20229 Mar
EPS$-0.03
Miss 19.2%
Q3 202210 Nov
EPS$-0.04
Miss 14.3%
Q2 202211 Aug
EPS$-0.04
Miss 6.7%
Q1 202212 May
EPS$-0.04
Miss 17.6%
Q4 202110 Mar
EPS$-0.17
Miss 325.0%
Q3 202110 Nov
EPS$-0.05
Beat 0.0%
Q2 202112 Aug
EPS$-0.03
Miss 18.2%
Q1 202113 May
EPS$-0.06
Miss 71.4%
Q4 202011 Mar
EPS$0.01
Beat 120.0%
Q3 20204 Nov
EPS$-0.05
Miss 11.1%
Q2 20206 Aug
EPS$-0.04
Beat 0.0%
Q1 20207 May
EPS$-0.06
Miss 20.0%
Q4 201912 Mar
EPS$-0.03
Beat 40.0%
Q3 201912 Nov
EPS$-0.04
Beat 20.0%
Q2 20198 Aug
EPS$-0.20
Miss 300.0%
Q1 20199 May
EPS$0.30
Beat 600.0%
Q4 201814 Mar
EPS$-0.32
Miss 357.1%
Q3 20188 Nov
EPS$-0.09
Miss 28.6%
Q2 20182 Aug
EPS$-0.03
Beat 57.1%
Q1 201810 May
EPS$-0.50
Miss 614.3%
Q4 201715 Mar
EPS$-0.58
Miss 728.6%
Q3 20179 Nov
EPS$0.12
Beat 250.0%
Q2 20172 Aug
EPS$-0.11
Miss 37.5%
Q1 201710 May
EPS$0.46
Beat 611.1%
Q4 201616 Mar
EPS$-0.05
Beat 64.3%
Q3 20163 Nov
EPS$0.30
Beat 314.3%
Q2 20169 Aug
EPS$-0.11
Beat 35.3%
Q1 201610 May
EPS$-0.19
Miss 35.7%
Q4 201515 Mar
EPS$-0.16
Beat 5.9%
Q3 20159 Nov
EPS$-0.17
Q2 201510 Aug
EPS$-0.12
Q1 20158 May
EPS$-0.13
Q4 201411 Mar
EPS$-0.14
Q3 20147 Nov
EPS$-0.12
Q2 201411 Aug
EPS$-0.15
Q1 201412 May
EPS$-0.14
Q4 201317 Mar
EPS$-0.34
Q3 201312 Nov
EPS$-0.16
Q2 20139 Aug
EPS$-0.14
Q1 201310 May
EPS$-0.15
Q4 201218 Mar
EPS$-0.12
Q3 20129 Nov
EPS$-0.10
Q2 20129 Aug
EPS$-0.11
Q1 201210 May
EPS$-0.10
Q4 201114 Mar
EPS$-0.11
Q3 20118 Nov
EPS$-0.08
Q2 20119 Aug
EPS$-0.09
Q1 20115 May
EPS$-0.07
Q4 201015 Mar
EPS$-0.06
Q3 201015 Nov
EPS$-0.11
Q2 201016 Aug
EPS$-0.06
Q1 20105 May
EPS$-0.04
Q4 200916 Feb
EPS$0.04
Q3 200912 Nov
EPS$-0.11
Q2 200913 Aug
EPS$-0.05
Q1 200915 May
EPS$-0.06
Q4 200820 Mar
EPS$-0.06
Q3 200819 Nov
EPS$-0.05
Q2 200814 Aug
EPS$-0.03
Q1 200815 May
EPS$-0.02
Q1 200814 Apr
EPS$-0.01
Q3 200714 Nov
EPS$-0.01
Q2 200714 Aug
EPS$-0.02
Q1 200715 May
EPS$-0.02
Q1 200717 Apr
EPS$-0.02
Q3 200614 Nov
EPS$-0.02
Q2 200616 Aug
EPS$-0.03
Miss 50.0%
Q1 200618 Apr
EPS$-0.03
Q1 200617 Apr
EPS$-0.02
Q3 200515 Nov
EPS$-0.02
Miss 50.0%
Q2 200515 Aug
EPS$-0.02
Miss 50.0%
Q1 200516 May
EPS$-0.04
Q4 200431 Mar
EPS$-0.03
Q3 200415 Nov
EPS$-0.03
Q2 200413 Aug
EPS$-0.02
Q1 200414 May
EPS$-0.10
Q4 200329 Mar
EPS$-0.04
Q3 200310 Nov
EPS$0.03
Q2 200313 Aug
EPS$-0.06
Q1 200315 May
EPS$-0.06
Q4 200231 Mar
EPS$-0.06
Q3 200214 Nov
EPS$-0.05
Q2 200214 Aug
EPS$-0.07
Q1 200215 May
EPS$-0.06
Q3 200131 Dec
EPS$-0.05
Q3 200130 Nov
EPS$-0.08
Q2 200114 Aug
EPS$-0.10
Q1 200115 May
EPS$-0.08
Q4 200030 Mar
EPS$-0.09
Q3 200014 Nov
EPS$-0.11
Q2 200014 Aug
EPS$-0.12
Q1 200012 May
EPS$-0.12
Q4 199930 Mar
EPS$-0.14
Q3 199912 Nov
EPS$-0.21
Q2 199913 Aug
EPS$-0.09
Q1 199917 May
EPS$-0.08
Q3 199816 Nov
EPS$-0.11
Q2 199828 Sept
EPS$-0.08
Q1 199824 Jun
EPS$-0.11
Beat 0.0%
Q4 199719 Mar
EPS$-0.06
Beat 40.0%
Q3 199714 Nov
EPS$-0.10
Q3 19978 Oct
EPS$-0.12
Miss 369.3%
Q2 19978 Jul
EPS$-0.06
Beat 0.0%
Q4 199620 Feb
EPS$-0.07
Miss 16.7%
Q3 199614 Nov
EPS$-0.09
Q2 199626 Sept
EPS$-0.06
Q4 199531 Mar
EPS$-0.07
Q3 199531 Dec
EPS$-0.07
Q2 199530 Sept
EPS$-0.04
Q1 199530 Jun
EPS$-0.08
Q4 199431 Mar
EPS$-0.07
Q3 199431 Dec
EPS$-0.08
Q2 199430 Sept
EPS$-0.06
Q1 199430 Jun
EPS$-0.07
Q4 199331 Mar
EPS$-0.05
Q3 199331 Dec
EPS$-0.08
Q2 199330 Sept
EPS$-0.06
Q1 199330 Jun
EPS$-0.07
Q4 199231 Mar
EPS$-0.05
Q3 199231 Dec
EPS$-0.06
Q2 199230 Sept
EPS$-0.05
Q1 199230 Jun
EPS$-0.04
Q4 199131 Mar
EPS$-0.04

Dividends

Dividend History

15 Dec 2003
Amount $0.0800

Stock Splits

Split History

31 Oct 1997Stock Split
Ratio3:1

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.